, Tracking Stock Market Picks
Enter Symbol:
Abbott Laboratories (ABT) [hlAlert]

down 10.63 %

Abbott Laboratories (ABT) rated Buy with price target $38 by UBS

Posted on: Friday,  Jan 11, 2013  11:25 AM ET by UBS

UBS rated Buy Abbott Laboratories (NYSE: ABT) on 01/11/2013. Previously UBS rated Buy Abbott Laboratories (NYSE: ABT) on 05/09/2008., when
the stock price was $51.07. Since then, Abbott Laboratories has lost 10.63% as of 10/07/2015's recent price of $45.64.
If you would have followed the previous UBS's recommendation on ABT, you would have lost 10.63% of your investment in 2707 days.

Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles life itself addressing important health needs from infancy to the golden years.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/11/2013 11:25 AM Buy
33.61 38.00
as of 12/13/2013
1 Week down  -3.01 %
1 Month down  -3.62 %
3 Months up  4.38 %
1 YTD down  -44.42 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/19/2012 3:25 PM Buy
65.63 72.00
3/19/2012 10:25 AM Buy
60.43 68.00
9/29/2009 10:25 AM Buy
49.31 55.00
7/17/2008 10:25 AM Buy
57.03 64.00
5/9/2008 8:25 AM Buy
51.07 61.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy